Edition:
United Kingdom

Ritter Pharmaceuticals Inc (RTTR.OQ)

RTTR.OQ on NASDAQ Stock Exchange Capital Market

3.28USD
18 Apr 2018
Change (% chg)

-- (--)
Prev Close
$3.28
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
12,996
52-wk High
$11.40
52-wk Low
$1.90

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2017 Dec '17 0.00 -0.110
Sep '17 0.00 -1.363
Jun '17 0.00 -1.407
Mar '17 0.00 -1.440
FY 2016 Dec '16 0.00 -7.427
Sep '16 0.00 -4.107
Jun '16 0.00 -4.822
Mar '16 0.00 -3.645
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Jun-18 1 0.00 0.00 0.00 0.00
Quarter Ending Sep-18 1 0.00 0.00 0.00 0.00
Year Ending Dec-18 2 0.00 0.00 0.00 0.00
Year Ending Dec-19 2 0.00 0.00 0.00 0.00
Earnings (per share)
Quarter Ending Jun-18 1 -0.80 -0.80 -0.80 -1.30
Quarter Ending Sep-18 1 -1.00 -1.00 -1.00 -1.40
Year Ending Dec-18 2 -2.77 -2.04 -3.50 -6.20
Year Ending Dec-19 1 -2.50 -2.50 -2.50 -4.63
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 199.23 33.50
P/E High - Last 5 Yrs. -- 289.53 46.07
P/E Low - Last 5 Yrs. -- 97.02 24.95
Beta -- 0.75 0.80
Price to Sales (TTM) -- 144.40 7.25
Price to Book (MRQ) 10.81 20.58 5.09
Price to Tangible Book (MRQ) 8.07 25.44 6.62
Price to Cash Flow (TTM) -- 129.04 25.50
% Owned Institutions 32.37 11.15 2.24

Dividends

  Company industry sector
Dividend Yield -- 0.28 1.53
Dividend Yield - 5 Year Avg -- 0.20 0.75
Dividend 5 Year Growth Rate -- 1.97 3.92
Payout Ratio(TTM) -- 9.04 20.54

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -- 80.75 8.68
Sales (TTM) vs TTM 1 Yr. Ago -- 96.50 11.19
Sales - 5 Yr. Growth Rate -- 34.30 8.22
EPS (MRQ) vs Qtr. 1 Yr. Ago 98.51 -65.81 22.73
EPS (TTM) vs TTM 1 Yr. Ago 78.40 -- --
EPS - 5 Yr. Growth Rate -- 48.46 10.28
Capital Spending - 5 Yr. Growth Rate -- 45.85 10.41

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 1.60 2.53
Current Ratio (MRQ) 8.42 6.05 3.61
LT Debt to Equity (MRQ) 0.00 23.27 11.39
Total Debt to Equity (MRQ) 0.00 25.63 14.02
Interest Coverage (TTM) -- -187.29 39.28

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 45.96 54.05
Gross Margin - 5 Yr. Avg. -- 55.59 52.18
EBITD Margin (TTM) -- -- --
EBITD - 5 Yr. Avg -- -148.41 15.90
Operating Margin (TTM) -- -557.58 4.09
Operating Margin - 5 Yr. Avg. -- -160.26 11.23
Pre-Tax Margin (TTM) -- -529.97 4.81
Pre-Tax Margin - 5 Yr. Avg. -- -166.50 11.54
Net Profit Margin (TTM) -- -518.89 1.42
Net Profit Margin - 5 Yr. Avg. -- -166.55 7.87
Effective Tax Rate (TTM) -- -0.18 30.96
Effective Tax Rate - 5 Yr. Avg. -- 18.25 24.26

Efficiency

  Company industry sector
Revenue/Employee (TTM) -- 24,228,298 813,295,447
Net Income/Employee (TTM) -- 1,142,384 95,590,786
Receivable Turnover (TTM) -- 6.52 5.56
Inventory Turnover (TTM) -- 2.30 3.44
Asset Turnover (TTM) 0.00 0.40 0.89

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -52.30 -0.71 10.51
Return on Assets - 5 Yr. Avg. -101.21 0.88 11.54
Return on Investment (TTM) -64.91 -0.66 13.17
Return on Investment - 5 Yr. Avg. -129.08 4.34 14.94
Return on Equity (TTM) -114.92 -2.84 14.98
Return on Equity - 5 Yr. Avg. -- 0.09 16.23
  1 Year 3 Year 5 Year
Sales % -- -- --
EPS (TTM) % 97.58 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Ritter Pharmaceuticals Inc

Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 32.37%
# of Holders: 23
Total Shares Held: 1,599,201
3 Mo. Net Change: 0
# New Positions: 0
# Closed Positions: 0
# Increased Positions: 0
# Reduced Positions: 0
# Net Buyers: 0
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.